Transforming growth factor-β activation of phosphatidylinositol 3-kinase is independent of Smad2 and Smad3 and regulates fibroblast responses via p21-activated kinase-2

被引:173
作者
Wilkes, MC
Mitchell, H
Penheiter, SG
Doré, JJ
Suzuki, K
Edens, M
Sharma, DK
Pagano, RE
Leof, EB
机构
[1] Mayo Clin, Ctr Canc, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[3] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA
[4] Mem Univ Newfoundland, Fac Med, Div Basic Med Sci, St John, NF A1B 3V6, Canada
关键词
D O I
10.1158/0008-5472.CAN-05-1522
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-beta (TGF-beta) stimulates cellular proliferation and transformation to a myofibroblast phenotype in vivo and in a subset of fibroblast cell lines. As the Smad pathway is activated by TGF-beta in essentially all cell types, it is unlikely to be the sole mediator of cell type-specific outcomes to TGF-beta stimulation. In the current study, we determined that TGF-beta receptor signaling activates phosphatidylinositol 3-kinase (PI3K) in several fibroblast but not epithelial cultures independently of Smad2 and Smad3. PI3K activation occurs in the presence of dominant-negative dynamin and is required for p21-activated kinase-2 kinase activity and the increased proliferation and morphologic change induced by TGF-beta in vitro.
引用
收藏
页码:10431 / 10440
页数:10
相关论文
共 55 条
  • [1] Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration
    Bakin, AV
    Tomlinson, AK
    Bhowmick, NA
    Moses, HL
    Arteaga, CL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) : 36803 - 36810
  • [2] Stromal fibroblasts in cancer initiation and progression
    Bhowmick, NA
    Neilson, EG
    Moses, HL
    [J]. NATURE, 2004, 432 (7015) : 332 - 337
  • [3] Tumor-stroma interactions
    Bhowmick, NA
    Moses, HL
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (01) : 97 - 101
  • [4] TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia
    Bhowmick, NA
    Chytil, A
    Plieth, D
    Gorska, AE
    Dumont, N
    Shappell, S
    Washington, MK
    Neilson, EG
    Moses, HL
    [J]. SCIENCE, 2004, 303 (5659) : 848 - 851
  • [5] Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
    Bhowmick, NA
    Ghiassi, M
    Bakin, A
    Aakre, M
    Lundquist, CA
    Engel, ME
    Arteaga, CL
    Moses, HL
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2001, 12 (01) : 27 - 36
  • [6] Chronic liver injury, TGF-β, and cancer
    Bissell, DM
    [J]. EXPERIMENTAL AND MOLECULAR MEDICINE, 2001, 33 (04) : 179 - 190
  • [7] Biology of the p21-activated kinases
    Bokoch, GM
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 : 743 - 781
  • [8] NGF exhibits a pro-apoptotic activity for human vascular smooth muscle cells that is inhibited by TGF beta 1
    Bono, F
    Lamarche, I
    Herbert, JM
    [J]. FEBS LETTERS, 1997, 416 (03): : 243 - 246
  • [9] Suppression of transforming growth factor-β-induced apoptosis through a phosphatidylinositol 3-kinase Akt-dependent pathway
    Chen, RH
    Su, YH
    Chuang, RLC
    Chang, TY
    [J]. ONCOGENE, 1998, 17 (15) : 1959 - 1968
  • [10] Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis
    Daniels, CE
    Wilkes, MC
    Edens, M
    Kottom, TJ
    Murphy, SJ
    Limper, AH
    Leof, EB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (09) : 1308 - 1316